Safety Study of IL-21/Ipilimumab Combination in the Treatment of Melanoma
Clinical trial NCT01489059 · COMPLETED
Trial details
- NCT number
- NCT01489059
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2014-06-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.